Back to Browse Journals » Clinical Interventions in Aging » Volume 4

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis

Authors Paula Rackoff

Published Date May 2009 Volume 2009:4 Pages 207—213

DOI http://dx.doi.org/10.2147/CIA.S4080

Published 5 May 2009

Paula Rackoff

Division of Rheumatology, Beth Israel Medical Center, New York, NY, USA

Abstract: Fragility fractures that occur as a result of osteoporosis are frequently associated with chronic pain and decreased quality of life as well as significant morbidity and mortality. Fracture reduction, however, is often less than optimal due to poor compliance with medications. Studies have demonstrated that risedronate, a heterocyclic nitrogen containing bisphosphonate can reduce vertebral, nonvertebral, and hip fracture incidence in postmenopausal women, in men, and in subsets of older patients at great risk of falls and fragility. The mechanism, efficacy, dosing options, and tolerability of risedronate are reviewed.

Keywords: osteoporosis, fracture

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Evolution of a domain conserved in microtubule-associated proteins of eukaryotes

Alex S Rajangam, Hongqian Yang, Tuula T Teeri, Lars Arvestad

Advances and Applications in Bioinformatics and Chemistry 2008, 1:51-69

Published Date: 23 September 2008

Inflammatory mediators: Parallels between cancer biology and stem cell therapy

A Patel, Andrew C Heinrich, Bobby Y Reddy, Pranela Rameshwar

Journal of Inflammation Research 2009, 2:13-19

Published Date: 4 February 2009

Eggshell membrane: A possible new natural therapeutic for joint and connective tissue disorders. Results from two open-label human clinical studies

Kevin J Ruff, Dale P DeVore, Michael D Leu, Mark A Robinson

Clinical Interventions in Aging 2009, 4:235-240

Published Date: 18 May 2009

Restless legs syndrome: differential diagnosis and management with pramipexole

Francesca Brindani, Francesca Vitetta, Franco Gemignani

Clinical Interventions in Aging 2009, 4:305-313

Published Date: 18 June 2009

Dietary habits and cardiovascular disease risk in middle-aged and elderly populations: a review of evidence

Eleni Tourlouki, Antonia-Leda Matalas, Demosthenes B Panagiotakos

Clinical Interventions in Aging 2009, 4:319-330

Published Date: 14 July 2009

Facial rejuvenation for middle-aged women: a combined approach with minimally invasive procedures

Alberto Goldman, Uwe Wollina

Clinical Interventions in Aging 2010, 5:293-299

Published Date: 14 September 2010

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure

Donatella Del Sindaco, Maria Denitza Tinti, Luca Monzo, et al

Clinical Interventions in Aging 2010, 5:381-393

Published Date: 3 December 2010

Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation

Castagna A, Rinaldi S, Fontani V, Mannu P, Lotti Margotti M

Clinical Interventions in Aging 2011, 6:201-206

Published Date: 25 July 2011